<DOC>
	<DOC>NCT00797108</DOC>
	<brief_summary>The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.</brief_summary>
	<brief_title>A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Bacterial</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<criteria>Hospitalized male or female patients 18 years of age or older. Female patients of childbearing potential must not be pregnant. Must exhibit at least two prespecified clinical symptoms/signs of pneumonia. Must require hospitalization for the pneumonia. Chest Xray must be suggestive of a pneumonia. Hospital or ventilator associated pneumonia. Patients with cystic fibrosis, pneumocystis carinii pneumonia or active tuberculosis. Previous treatment for the current pneumonia episode received for more than 24 hours. Allergies to penems or beta lactams.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>